Back to News
Market Impact: 0.25
Sensible Biotechnologies Secures $47 Million to Advance Naturally Modified mRNA Platform and Unlock Next Generation of mRNA Medicines
Source: Business Wire
Healthcare & BiotechPrivate Markets & VentureTechnology & Innovation
Sensible Biotechnologies secured $47 million to advance its naturally modified mRNA platform and develop next-generation mRNA medicines. The headline provides no further details on the financing terms or development milestones.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
More News
- Singapore's Temasek warns of the ‘biggest risk’ facing markets right now
- A 32% beat, a +6% jump: the IT solutions name our models picked in July
- What Marvell's rosy long-term guidance means for our AI chip stocks
- Meta may ditch the idea of a cloud business for Muse. We think that’s a good trade
- Malaysia 2027 budget to tackle living costs, fiscal risks as election looms
- Google teams with nuclear power giant to give reactors a tune-up